Projects per year
Personal profile
Headline
ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
Fingerprint
Dive into the research topics where Alan Shih is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
IDH inhibitors in preclinical models of leukemia
American Society of Clinical Oncology
1/01/13 → …
Project: Research
-
-
-
An MDM2 degrader for treatment of acute leukemias
Marcellino, B. K., Yang, X., Ümit Kaniskan, H., Brady, C., Chen, H., Chen, K., Qiu, X., Clementelli, C., Herschbein, L., Li, Z., Elghaity-Beckley, S., Arandela, J., Kelly, B., Hoffman, R., Liu, J., Xiong, Y., Jin, J. & Shih, A. H., Feb 2023, In: Leukemia. 37, 2, p. 370-378 9 p.Research output: Contribution to journal › Article › peer-review
-
Murine Modeling of Myeloproliferative Neoplasms
Chen, K. & Shih, A. H., Apr 2021, In: Hematology/Oncology Clinics of North America. 35, 2, p. 253-265 13 p.Research output: Contribution to journal › Review article › peer-review
-
Safety and Efficacy: Clinical Experience of Venetoclax in Combination with Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies
Feld, J., Tremblay, D., Dougherty, M., Czaplinska, T., Sanchez, G., Brady, C., Kremyanskaya, M., Bar-Natan, M., Keyzner, A., Marcellino, B. K., Gabrilove, J., Navada, S. C., Silverman, L. R., El Jamal, S. M., Mascarenhas, J. & Shih, A. H., 9 Apr 2021, In: HemaSphere. 5, 4, e549.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations -
Somatic mutations drive specific, but reversible, epigenetic heterogeneity states in AML
Li, S., Chen, X., Wang, J., Meydan, C., Glass, J. L., Shih, A. H., Delwel, R., Levine, R. L., Mason, C. E. & Melnick, A. M., Dec 2020, In: Cancer Discovery. 10, 12, p. 1934-1949 16 p.Research output: Contribution to journal › Article › peer-review
12 Scopus citations -
Venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia secondary to a myeloproliferative neoplasm
Tremblay, D., Feld, J., Dougherty, M., Czaplinska, T., Sanchez, G., Kremyanskaya, M., Bar-Natan, M., Shih, A. H., Keyzner, A. & Mascarenhas, J., Nov 2020, In: Leukemia Research. 98, 106456.Research output: Contribution to journal › Letter › peer-review
13 Scopus citations
Press/Media
-
American Society of Hematology Announces 2023 Scholar Award Recipients
15/03/23
1 item of Media coverage
Press/Media
-
AMERICAN SOCIETY OF HEMATOLOGY ANNOUNCES 2023 SCHOLAR AWARD RECIPIENTS
2/02/23
1 item of Media coverage
Press/Media